Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline

(2013) Koen Demyttenaere et al.   CNS SPECTRUMS

New approaches to the pharmacological management of generalized anxiety disorder

(2013) Massimiliano Buoli et al.   EXPERT OPINION ON PHARMACOTHERAPY

Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin

(2013) Charlotte Both et al.   Expert Review of Neurotherapeutics

Agomelatina: fallo hepático fulminante en paciente con hígado graso

(2013) Fernando Gruz et al.   Gastroenterologia y Hepatologia

Agomelatine

(2013) E Karakus et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression

(2013) Dan J Stein et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice

(2013) Domenico De Berardis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder

(2013) Reinhard Heun et al.   JOURNAL OF CLINICAL PSYCHIATRY

Agomelatine and Hepatotoxicity: Implications of Cumulated Data Derived from Spontaneous Reports of Adverse Drug Reactions

(2013) M. Gahr et al.   PHARMACOPSYCHIATRY

Agomelatine-induced hepatotoxicity

(2013) Matej Štuhec   WIENER KLINISCHE WOCHENSCHRIFT

Pregabalin for the treatment of generalized anxiety disorder: an update

(2013) David Baldwin et al.   Neuropsychiatric Disease and Treatment

Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal

(2012) B. Dell’osso et al.   EUROPEAN PSYCHIATRY

Antidepressant efficacy of agomelatine versus SSRI/SNRI

(2012) Siegfried Kasper et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Agomelatine Prevents Relapse in Generalized Anxiety Disorder

(2012) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder

(2012) Giovanni Martinotti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Agomelatine-Induced Akathisia with Concomitant Duloxetine Medication: A Case Report

(2012) C. Imboden et al.   PHARMACOPSYCHIATRY

The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI

(2012) G. Laux et al.   PHARMACOPSYCHIATRY

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder

(2012) Jean Endicott et al.   Neuropsychiatric Disease and Treatment

Clinically Significant Drug Interactions with Newer Antidepressants

(2011) Edoardo Spina et al.   CNS DRUGS

Agomelatine: A narrative review

(2011) Koen Demyttenaere   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pharmacological treatment of generalized anxiety disorder

(2011) Jennifer A Reinhold et al.   EXPERT OPINION ON PHARMACOTHERAPY

Agomelatine for the treatment of major depressive disorder

(2011) Regina M Carney et al.   EXPERT OPINION ON PHARMACOTHERAPY

Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder

(2011) Alfredo Carlo Altamura et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Evidence-based pharmacological treatment of generalized anxiety disorder

(2011) David S. Baldwin et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Novel melatonin-based therapies: potential advances in the treatment of major depression

(2011) Ian B Hickie et al.   LANCET

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation

(2010) Michele Fornaro et al.   Current Neuropharmacology

Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study

(2010) Alfredo Carlo Altamura et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

(2010) Siegfried Kasper et al.   JOURNAL OF CLINICAL PSYCHIATRY

Diazepam Discontinuation Through Agomelatine in Schizophrenia With Insomnia and Depression

(2010) Armando L. Morera-Fumero et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

(2010) Christian de Bodinat et al.   NATURE REVIEWS DRUG DISCOVERY

Agomelatine in the treatment of panic disorder

(2010) Michele Fornaro   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Slow vs standard up-titration of paroxetine in the treatment of panic disorder: A prospective randomized trial

(2010) Massimiliano Buoli et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults

(2010) Robert Howland   Neuropsychiatric Disease and Treatment

Agomelatine

(2009) Maurizio Popoli   CNS DRUGS

Agomelatine Treatment of Major Depressive Disorder

(2008) Christian R Dolder et al.   ANNALS OF PHARMACOTHERAPY

Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system

(2008) Luis San et al.   EUROPEAN PSYCHIATRY

Efficacy of Agomelatine in Generalized Anxiety Disorder

(2008) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Agomelatine

(2008) &NA;   Drugs in research & development